TCTR20220125001Not yet recruitingPhase 2
Efficacy and safety of Herbal Drink in moderate COVID-19 patients: pilot study
Giving Mind Nirvana Soul Foundation0 sites100 target enrollmentStarted: January 25, 2022Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20 Years to 60 Years (—)
- Sex
- All
Inclusion Criteria
- •1. 20 to 60 years of age 2. Diagnosis of COVID-19 infection confirmed by RT-PCR test for SAR-CoV-2 3. moderate COVID-19 symptoms 4. No uncontrollable underlying disease 5. Onset of symptoms is within 5 days or positive RT-PCR for SAR-CoV-2 within 5 days 6. Signed informed consent provided by patient 7. Willing to stay at research site at least 10 days
Exclusion Criteria
- •1. COVID19 positive based on Antigen test but PCR negative 2. Severe or critical clinical conditions (Glasgow coma scale less than 14) 3. Severe COVID-19 4. Patient who is on mechanical ventilator 5. Abnormal chest x-ray 6. Dyspnea or respiratory rate above 30 per minute 7. Hypoxia or oxygen saturation less than 96 percent 8. Underlying diseases including Diabetes mellitus, uncontrollable hypertension 9. Abnormal liver function test: ALT/AST increased 5 times higher than the upper limit of normal or with Child Pugh C 10. Renal failure or Creatinine clearance (Cockcroft-Gault Equation) less than 30 ml/min or having hemodialysis/peritoneal dialysis 11. Known allergy or hypersensitivity to Herbal Drink 12. Pregnant (female of childbearing age with positive urine pregnancy test) or Lactating female
Investigators
Similar Trials
Not yet recruiting
Phase 2
Efficacy and safety of Herbal Drink in mild to moderate Covid-19 patients: pilot studyconfirmed RT-PCR for SAR-CoV-2 patients with mild to moderate symptomsmild-symptom covid-19 patients, moderate-symptom covid-19 patients, Herbal Drink, Favipiravir, viral clearanceTCTR20211220001Giving Mind Nirvana Soul Foundation100
Not yet recruiting
Phase 2
Efficacy and safety of Herbal Drink in mild to severe COVID-19 patients: pilot studymild-symptom covid-19 patients, moderate-symptom covid-19 patients, severe-symptom covid-19 patients, Herbal Drink, Favipiravir, viral clearanceconfirmed RT-PCR for SAR-CoV-2 patients with mild to severe symptomsTCTR20220204005Giving Mind Nirvana Soul Foundation100
Recruiting
Phase 3
Effectiveness of herbal capsule in COVID-19COVID-19.COVID-19U07.1IRCT20200330046899N1Kerman University of Medical Sciences50
Not yet recruiting
Phase 3
Evaluation of herbal formulation in contact dermatitisCTRI/2023/07/055420Plant Ayu Life Sciences LLP Pune
Not yet recruiting
Phase 3
Evaluating the effectiveness of herbal toothpaste in the reduction of tooth debris and gum diseases in adultsCTRI/2024/02/062753Dabur Research & Development Centre